Full-Spectrum Support for
Cross-Border Biopharma

Out-licensing & in-licensing facilitation between Chinese biotechs and global pharma. 250+ clients, 400+ projects.

• 250+ Chinese clients
• 400+ active projects
• 25+ MNC connections

We connect biopharma companies with pre-screened US venture capital and provide executive and scientific recruitment support — drawing on one of the most extensive personal networks in US-China biopharma to place the right people at the right time.

• 10+ US VC firm relationships
• 16,000+ network connections
• Scientific & commercial roles

Selecting the right contract research or manufacturing partner is one of the highest-stakes decisions in drug development. We leverage deep relationships across the China CRO/CDMO landscape — and beyond — to match clients with partners whose capabilities align with their program requirements.

• Small molecules & biologics
• Cell & gene therapy CDMOs
• Tech transfer support

Understanding the China biopharma market requires specialized knowledge that is difficult to source externally. Our proprietary market reports, combined with BioLink Weekly, provide the depth and currency needed to make confident strategic decisions.

• Regulatory landscape analysis
• Competitive intelligence
• BioLink Weekly newsletter